CRISPR Therapeutics' John Martin talks about why the company chose Framingham
Last summer, Life Sciences company CRISPR Therapeutics, announced they would be building a new manufacturing facility in Framingham. Choose Framingham checked in with John Martin, the company's Head of Government Affairs, about the state of the new facility, their thoughts on the City's growing Life Sciences sector, and what advice they would give to other employers interested in choosing Framingham as they grown their business. Click here to read the entire interview.